Skip to content

Macrophage/Monocyte Driven Inflammation and Anesthetic Sensitivity in Aging

Role of Macrophage/Monocyte Mediated Inflammatory Response in Diminished Anesthetic Requirements During Aging

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07372417
Acronym
MACRO-AGE
Enrollment
60
Registered
2026-01-28
Start date
2026-01-25
Completion date
2027-06-15
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Anesthesia Brain Monitor, Anesthesia Depth Monitoring, Blood-Brain Barrier Permeability, Inflammaging, Inflammation, Inflammation Biomarkers, Monocyte

Keywords

Aging, Inflammation, General Anesthesia, Anesthetic Sensitivity, Cytokines, Alpha Oscillations, Blood Brain Barrier, Monocyte phenotype, macrophage phenotype

Brief summary

The goal of this observational study is to determine whether macrophage/monocyte mediated inflammatory signaling contributes to reduced anesthetic requirements in older adults undergoing major abdominal surgery. The main questions it aims to answer are: * Is there a difference in anesthetic dosing requirements (minimum effective dose) between young and older patients undergoing major abdominal surgery? * How do electroencephalographic (EEG) signatures under anesthesia correlate with age and systemic inflammatory markers? * Is there an association between age, levels of circulating inflammatory cytokines, and monocyte/macrophage phenotypes with anesthetic requirements? If there is a comparison group: Researchers will compare older adult patients undergoing major abdominal surgery to younger adult patients undergoing major abdominal surgery to see if macrophage/monocyte-mediated inflammatory signaling influences anesthetic sensitivity and the risk of postoperative neurocognitive complications in the older population. Participants will: * Receive general anesthesia for major abdominal surgery, with continuous recording of anesthetic dose requirements. * Undergo electroencephalographic (EEG) monitoring during the anesthetic period. * Provide blood samples for the measurement of circulating inflammatory cytokines and the assessment of monocyte phenotypes. * Provide peritoneal tissue samples (collected during surgery) to evaluate tissue macrophage populations. * Provide cerebrospinal fluid (CSF) samples to assess biomarkers of blood-brain barrier permeability.

Interventions

None listed

Sponsors

University of Chile
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age between 18-30 years or over 60 years old * Scheduled for abdominal surgery * General anesthesia planned with or without spinal anesthesia * Able and willing to provide written informed consent.

Exclusion criteria

* Chemotherapy or systemic corticosteroid use within the past 2 weeks. * Pregnancy. * Active sepsis or systemic infection. * Emergency surgery. * Requirement of ketamine or dexmedetomidine during the first hour of anesthesia. * History or diagnosis of: stroke with persistent neurological deficit, dementia, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, central nervous system autoimmune disorders, systemic autoimmune diseases, or infectious diseases of the central nervous system. * Current treatment with immunomodulatory medications. * Psychiatric disorders with psychotic features. * Use of psychoactive or psychotropic recreational drugs within the week prior to surgery.

Design outcomes

Primary

MeasureTime frameDescription
Frontal EEG alpha-band powerPerioperativeRelative EEG alpha power during surgery under general anesthesia guided by standard age-adjusted dosing

Secondary

MeasureTime frameDescription
Time-to-loss of consciousnessPerioperativeDuring propofol slow induction, the time required for unresponsiveness to verbal stimuli
Intraoperative anesthetic requirementsPerioperativeTotal dose and infusion rate of propofol and/or sevoflurane adjusted using frontal EEG monitoring
Time to emergencePerioperativeTime in minutes to eye opening since end of anesthesia, with verbal stimuli.
Cytokine circulating profileBaselineSerum inflammatory cytokine profile
Monocyte/Macrophage phenotype in blood and peritoneal samplesPeriproceduralinflammatory cell Pheontype present in circulating blood (monocytes) and in peritoneal lavage and tissue samples.
Blood-brain barrier permeabilityBaselineCSF biomarkers present: albumin, cytokines.

Countries

Chile

Contacts

CONTACTCatalina Andrea Díaz Papapietro, Anesthesiologist, MD PhD (c)
catalinadiaz@ug.uchile.cl+56229789405
CONTACTRodrigo Gutiérrez Rojas, Assitant Professor, MD PhD
rodrgutierrez@uchile.cl+56229789405
STUDY_CHAIRAntonello Penna Silva, Anesthesia Professor, MD PhD

Brain and Anesthesia Laboratory (BAL), University of Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026